You are currently viewing a new version of our website. To view the old version click .

New Insights into the Treatment of Colorectal Cancer in the Era of Precision Medicine

This special issue belongs to the section “Medical Research“.

Special Issue Information

Dear Colleagues,

During the last 20 years, we have observed a dramatic revolution in the therapeutic scenario of patients with colorectal cancer (CRC), with a shift from single-agent chemotherapy drugs to personalized medicine.

This change has been possible thanks to increased knowledge of the molecular biology of CRC, leading to the clinical development of tailored therapies.  Unfortunately, not all patients with CRC harboring a driver gene alteration respond to target therapy. Therefore, major efforts are needed to increase understanding of tumor heterogeneity, identify predictive biomarkers of response, find new combinatory strategies and improve patient outcomes.

Thus, the aim of this Special Issue of Life is to summarize the novel advances in CRC research that could lead to the optimization of patient selection and, therefore, to more effective treatments.

We encourage the submission of original research, reviews as well as high-quality case reports related to the latest progress on the theme topic.

Dr. Davide Ciardiello
Dr. Alessandro Parisi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colorectal cancer 
  • target therapies 
  • predictive biomarkers 
  • immunotherapy 
  • liquid biopsy 
  • translational research 
  • rechallenge 
  • epigenetics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Life - ISSN 2075-1729